Table 2 Endoscopic findings and main laboratory indicators of patients in the study
From: Endoscopic injection sclerotherapy for treating recurrent bleeding of small bowel angioectasias
Variables | Total cohort (n = 66) | Control group (n = 35) | EIS group (n = 31) | P-value |
|---|---|---|---|---|
Endoscopic findings,n(%) | ||||
Type of lesions | ||||
Type 1a | 18 (27.27) | 10 (28.57) | 8 (25.81) | 0.801 |
Type 1b (with or without type 1a lesions) | 48 (72.73) | 25 (71.43) | 23 (74.19) | |
Location of most lesions | ||||
Jejunum | 7 (10.61) | 1 (2.86) | 6 (19.35) | 0.076 |
Ileum | 59 (89.39) | 34 (97.14) | 25 (80.65) | |
Number of lesions | ||||
< 3 | 17 (25.76) | 15 (42.86) | 2 (6.45) | <0.001* |
≥ 3 | 49 (74.24) | 20 (57.14) | 29 (93.55) | |
Active oozing/bleeding | ||||
Yes | 7 (10.61) | 2 (5.71) | 5 (16.13) | 0.332 |
No | 59 (89.39) | 33 (94.29) | 26 (83.87) | |
Main laboratory indicators, mean ± SD, range | ||||
HB (g/L) | 79.14 ± 21.52 46.00-140.00 | 77.83 ± 21.53 46.00-129.00 | 80.61 ± 21.76 47.00-140.00 | 0.604 |
PLT (10^9/L) | 188.90 ± 87.44 33.00-426.00 | 178.70 ± 68.51 41.00-318.00 | 200.40 ± 104.80 33.00-426.00 | 0.330 |
PT (seconds) | 11.37 ± 0.99 9.60–15.30 | 11.34 ± 1.08 9.60–15.30 | 11.41 ± 0.89 9.90–14.60 | 0.788 |
APTT (seconds) | 26.07 ± 5.36 16.60–49.80 | 26.40 ± 6.35 16.60–49.80 | 25.71 ± 4.05 16.80–35.80 | 0.596 |
TBIL (umol/L) | 10.83 ± 7.89 1.80–44.30 | 10.53 ± 6.79 2.80–42.90 | 11.17 ± 9.08 1.80–44.30 | 0.744 |
ALB (g/L) | 36.20 ± 4.79 22.50–45.20 | 36.11 ± 5.47 22.50–45.20 | 36.30 ± 3.97 26.70–44.40 | 0.876 |